Final estimates for tecovirimat PK models in mpox-infected NHPs and uninfected humans used in our analysis.

Nguyen, Bach Tran; Marc, Aurélien; Suñer, Clara; Marks, Michael; Ubals, Maria; Hernández-Rodríguez, Águeda; Melendez, María Ángeles; Hruby, Dennis E.; Russo, Andrew T.; Mentré, France; Mitjà, Oriol; Grosenbach, Douglas W.; Guedj, Jérémie

doi:10.1371/journal.pbio.3002249.s013

pbio.3002249.s013.docx (14.85 kB)

Final estimates for tecovirimat PK models in mpox-infected NHPs and uninfected humans used in our analysis.

journal contribution

posted on 2023-12-21, 18:25 authored by Bach Tran Nguyen, Aurélien Marc, Clara Suñer, Michael Marks, Maria Ubals, Águeda Hernández-Rodríguez, María Ángeles Melendez, Dennis E. Hruby, Andrew T. Russo, France Mentré, Oriol Mitjà, Douglas W. Grosenbach, Jérémie Guedj

PK, pharmacokinetic; NHP, nonhuman primates; wt: weight; dose: dose level in mg/kg; IIV, interindividual variability; IOV, intra-occasion variability; NA, not available.

(DOCX)